Hamideh is a specialist in RNA delivery technologies, with her research focusing on RNA therapeutics and advanced drug delivery systems. She leads work on developing and optimizing delivery technologies critical to the safe and effective distribution of RNA-based medicines. Dr. Parhiz was a scientific co-founder of Capstan Therapeutics that was acquired by AbbVie.